New measures to tackle racial inequality, as Imperial pledges to ‘do better’
Cholesterol levels dropping in Western nations – but rising in Asia
Academic Year 2020/21: Imperial announces 'multi-mode' teaching for Autumn term
CDDS researchers work across a wide range of diseases, from infection and inflammation to oncology, cardiovascular disease and neurodegeneration.
View our network of disease experts
The CDDS brings together expertise in new screening technologies, target deconvolution, ultrasensitive biomarker analysis, microfluidic devices, and more.
View technology areas
We are developing small molecule, peptide, biological and cell-based modalities across a wide range of target classes and novel modes of action.
View target classes